Though further work is needed to identify the targets involved in ChoPlas-induced alterations of cell cycle regulation, our data show that CDK4, CyclinE and CDK2 levels were attenuated by exogenous ChoPlas treatment, suggesting that exogenous ChoPlas inhibits hepatoma cell proliferation through its action on cell cycle regulatory factors. This evidence concerns the gene CDK2 and hepatocellular carcinoma.